📉 BNTX leads biotech rout — median loss 6.62% as biggest stock losers today include GSIW, ENLT, CVLT | March 11, 2026
Spotlight on BNTX, GSIW, ENLT and more. The data suggests a broadly negative day for high-beta growth and biotech names, with many deep decliners and episodic extreme volume spikes. Several stocks (BNTX, GSIW, CVLT) display capitulation characteristics that may produce short-term bounces if accompanied by continued above-average volume and improving range_position. Conversely, expensive valuations and numerous unprofitable listings increase the likelihood of continued volatility—prioritize volume confirmation, conservative sizing, and clear stops when approaching these names.
Top Picks
Disclaimer: This AI-generated analysis is for educational and informational purposes only. It does not constitute financial advice. Always do your own research and consult with a licensed financial advisor before making investment decisions.
Market Overview
Key Observation
The Day Losers list shows broad, sizable declines (median % loss 6.62%) with many deep decliners across growth/biotech names; several names exhibit large intraday volume spikes suggesting news-driven selling or capitulation.
Volume Analysis
Median volume spike is modest (1.4x) but multiple names show extreme volume_ratio (>4x: BNTX, GSIW, CRSP, ENLT) indicating concentrated attention; overall volume profile points to episodic, stock-specific events rather than uniform market selling.
Top PicksShowing 2 of 5
BNTX
Analysis
The data suggests BNTX is a high-probability bounce candidate: very large volume spike (11.03x) coincides with a steep drop (-17.88%) and a low range_position (9.8) near the lower portion of its 52-week range. Analyst sentiment is Strong Buy and market_cap is sizeable ($21.05B), implying institutional interest. Momentum score is moderate (20) despite a downtrend, consistent with a potential mean-reversion event.
Key Metrics
change_pct -17.88%, volume_ratio 11.03, range_position 9.8
Risk Factors
Downtrend persists; 'Unprofitable' valuation classification and high intraday volatility.
Suggested Action
The data suggests watch for volume confirmation (sustained volume_ratio >2x) and an improving range_position before considering entry; use a predefined stop near today's low to manage risk.
GSIW
Analysis
GSIW shows extreme intraday selling (-18.49%) with a large volume_ratio (6.31) and a very low range_position (5.4), consistent with capitulation in a recent IPO. The mix of heavy volume and proximity to its low portion of the range suggests a potential short-term reversal if buyers return. Momentum is low (15) and valuation is 'Unprofitable', signaling elevated execution risk.
Key Metrics
change_pct -18.49%, volume_ratio 6.31, range_position 5.4
Risk Factors
Recent IPO status, unprofitable valuation, wide 52-week range (8.0 - 358.0) implying high structural volatility.
Suggested Action
The data suggests monitor for a rebound on continued above-average volume and tightening intraday range; consider only small position sizes given IPO and valuation risk.
+3 more top picks available
Sign up free to unlock all picks
Unlock Full Analysis
Sign up for free to access the complete Day Losers Analysis analysis
You're missing out on:
By signing up, you agree to our Terms of Service and Privacy Policy